Nihon Kohden Corp
TSE:6849
Gross Margin
Nihon Kohden Corp
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JP |
|
Nihon Kohden Corp
TSE:6849
|
280.6B JPY |
51%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.1B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.1B USD |
67%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
68%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.5B USD |
64%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD |
66%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
45%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
38%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
79%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
256.5B CNY |
64%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
31.3B USD |
58%
|
Nihon Kohden Corp
Glance View
Nihon Kohden Corp., founded in 1951, has evolved into a pioneering force in the medical technology landscape, blending innovation with a storied heritage. This Tokyo-based firm established its foothold by developing advanced medical electronic devices, initially focusing on EEG (electroencephalography) machines. As medical science rapidly advanced, Nihon Kohden expanded its portfolio to include a range of diagnostic and monitoring equipment. Today, the company's product line encompasses patient monitors, defibrillators, electrocardiographs, and clinical information systems, serving various healthcare domains. This focus on critical care and diagnostics creates consistent demand across global hospitals and clinics, reinforcing its reputation as a dependable partner in medical excellence. Financially, Nihon Kohden's business model thrives on a dual revenue structure: product sales and after-sales service. By manufacturing and distributing complex equipment directly and through a network of distributors, the company captures a significant share of initial capital expenditure in healthcare institutions. Furthermore, it enhances this income by offering ongoing equipment maintenance, training, and customer support, forming long-term relationships with healthcare providers. These services ensure not only a steady revenue stream beyond the initial sale but also brand loyalty and trust in an industry where precision and reliability are paramount. As it continues to innovate, Nihon Kohden's commitment to addressing the evolving needs of healthcare practitioners fortifies its market position and operational success.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Nihon Kohden Corp's most recent financial statements, the company has Gross Margin of 51.5%.
You don't have any saved screeners yet